Definition and epidemiology
Clitoromegaly refers to enlargement of the clitoris beyond normal size reference ranges for age. There is no single universally accepted cutoff, but commonly cited thresholds are a clitoral glans width greater than approximately 6 mm in a term neonate and greater than roughly 1 cm (with a clitoral index, length x width, above 35 mm squared) in an adult woman.
It is a sign rather than a single disease, and it sits at the intersection of pediatric endocrinology, gynecology, and disorders of sex development (DSD) care.
- Most common cause overall in neonates: congenital adrenal hyperplasia (CAH), especially 21-hydroxylase deficiency
- Most common cause in reproductive-age women: polycystic ovary syndrome (PCOS) and other hyperandrogenic states, though severe clitoromegaly from PCOS alone is uncommon
- Rare but important: androgen-secreting ovarian or adrenal tumors, especially when onset is rapid in a previously normal patient
- Idiopathic/physiologic variant: some degree of clitoral prominence can be a normal finding, particularly in premature infants
- Most common cause of clitoromegaly plus ambiguous genitalia in a newborn is 21-hydroxylase deficiency CAH
- Check 17-hydroxyprogesterone first in a virilized neonate
- Salt-wasting CAH presents with vomiting, dehydration, hyponatremia, and hyperkalemia in the first weeks of life
- Rapid-onset virilization in an adult woman suggests an androgen-secreting tumor, not PCOS
- 11-beta-hydroxylase deficiency CAH causes virilization plus hypertension (low renin)
- Current guidelines favor delaying irreversible genital surgery in infants with DSD when not medically urgent
- Nerve-sparing clitoroplasty aims to preserve sensation when surgery is performed
- PCOS rarely causes severe clitoromegaly; look for a tumor if clitoral enlargement is marked
Etiology and risk factors
Congenital causes (present at birth or early childhood)
- Congenital adrenal hyperplasia (21-hydroxylase deficiency most common; 11-beta-hydroxylase deficiency less common)
- Maternal androgen or progestin exposure during pregnancy (exogenous hormones, certain anticonvulsants)
- Maternal virilizing tumor (luteoma of pregnancy, androgen-secreting ovarian tumor)
- Aromatase deficiency in the fetus or placenta
- Disorders of sex development with ovotesticular or 46,XY DSD features
- Mixed gonadal dysgenesis
Acquired causes (later childhood, adolescence, adulthood)
- Polycystic ovary syndrome
- Androgen-secreting ovarian tumors (Sertoli-Leydig cell tumor) or adrenal tumors/carcinoma
- Cushing syndrome
- Exogenous androgen use (anabolic steroids, testosterone therapy)
- Chronic topical corticosteroid use on the vulva (local pseudo-enlargement from clitoral adhesions/lymphedema is a differential consideration)
- Lymphatic obstruction or chronic vulvar edema (non-androgenic mimicker)
Risk factors
- Family history of CAH or consanguinity
- Maternal use of androgenic or progestational medications in pregnancy
- Features of hyperandrogenism (hirsutism, acne, menstrual irregularity) in the acquired setting
Pathophysiology
The clitoris is embryologically homologous to the penis, developing from the genital tubercle. Its growth is androgen-dependent, driven primarily by dihydrotestosterone (DHT) acting through androgen receptors in genital skin and underlying erectile tissue.
In CAH, a block in cortisol synthesis (most often 21-hydroxylase deficiency) causes accumulation of upstream precursors that are shunted into the androgen pathway, exposing the fetus to excess androgens in utero. Because clitoral and labial development occurs early in gestation, this exposure virilizes the external genitalia, producing clitoromegaly with variable labial fusion.
In postnatal or adult-onset causes, excess circulating androgens (from ovarian or adrenal tumors, exogenous sources, or chronically elevated ovarian androgen production as in PCOS) act on already-differentiated clitoral tissue, causing hypertrophy of the glans and corpora rather than the fusion abnormalities seen with prenatal exposure.
Non-androgenic clitoromegaly (lymphedema, neurofibromatosis-related neurofibroma, chronic topical steroid-induced atrophy with pseudo-enlargement, or benign cysts) reflects local structural or infiltrative processes rather than hormonal drive, and is an important differential to keep in mind.
Clinical features
- Visibly enlarged clitoral glans, sometimes with a prominent clitoral hood or partial labial fusion in congenital cases
- In neonates: ambiguous-appearing genitalia, possible non-palpable gonads, and in salt-wasting CAH, vomiting, dehydration, and failure to thrive within the first weeks of life
- In children/adolescents: precocious pubarche, accelerated growth velocity, advanced bone age, acne
- In adults: hirsutism, deepening voice, temporal balding, increased muscle mass, menstrual irregularity or amenorrhea (features of virilization suggest a more aggressive androgen source such as a tumor)
- Rapid onset of virilizing signs over weeks to months strongly suggests an androgen-secreting tumor rather than PCOS
- Associated findings depending on cause: hyperpigmentation (from elevated ACTH in CAH), hypertension (11-beta-hydroxylase deficiency CAH, Cushing syndrome), or abdominal/pelvic mass on exam
Diagnosis
Diagnosis combines careful genital examination with hormonal and sometimes imaging/genetic workup, tailored to age of onset and tempo of symptoms.
History and examination
- Document clitoral glans width/length, degree of labial fusion (Prader staging if DSD suspected), and palpate for gonads
- Pubertal (Tanner) staging in children/adolescents
- Ask about maternal medication/hormone exposure during pregnancy for neonatal cases
- Assess tempo of virilization in adults (rapid onset raises suspicion for tumor)
Laboratory evaluation
- 17-hydroxyprogesterone (markedly elevated in 21-hydroxylase deficiency CAH) - first-line test in a virilized neonate
- Total and free testosterone, DHEA-S (adrenal source if very high), androstenedione
- Serum electrolytes in neonates (hyponatremia/hyperkalemia suggest salt-wasting CAH)
- Karyotype and/or genetic testing when DSD is suspected
- ACTH stimulation test if baseline 17-OHP is borderline
- LH/FSH, cortisol/ACTH if Cushing syndrome is suspected
Imaging
- Pelvic/abdominal ultrasound to assess gonads, uterus, and look for ovarian or adrenal masses
- MRI of adrenal glands or pelvis if a tumor is suspected and ultrasound is inconclusive
- Genitogram in complex DSD cases to delineate internal anatomy
| Suspected cause | Key first test |
|---|---|
| Neonatal CAH | 17-hydroxyprogesterone |
| Adult androgen-secreting tumor | Testosterone, DHEA-S plus imaging |
| PCOS | Clinical criteria plus androgen panel, pelvic ultrasound |
| Cushing syndrome | Overnight dexamethasone suppression test |
Differential diagnosis
- Normal anatomic variant, especially in preterm infants
- Labial fusion or labial hypertrophy misread as clitoral enlargement
- Vulvar lymphedema or lymphatic malformation
- Clitoral neurofibroma (consider neurofibromatosis type 1)
- Epidermoid or other clitoral cysts
- Clitoral priapism (rare, painful, and acute)
- 46,XY DSD with undervirilized male genitalia mistaken for enlarged clitoris
- Chronic topical corticosteroid-induced vulvar changes
Management
Management is directed at the underlying cause; genital surgery is not automatic and decisions should involve a multidisciplinary DSD team (pediatric endocrinology, urology/gynecology, genetics, psychology) and, critically, the family and, when appropriate, the patient themselves.
Medical management
- CAH: glucocorticoid replacement to suppress excess ACTH-driven androgen production, with mineralocorticoid replacement if salt-wasting; lifelong monitoring and stress dosing during illness
- Androgen-secreting tumors: surgical resection of the tumor is primary treatment
- PCOS-related mild clitoromegaly: usually does not require clitoral surgery; manage underlying hyperandrogenism and metabolic features per PCOS guidelines
- Discontinue any offending exogenous androgen/anabolic agent
Surgical considerations
- Current major guidelines (including statements from pediatric endocrine and urology societies) emphasize deferring irreversible genital surgery in infants with DSD unless medically necessary, favoring shared decision-making and, where feasible, delaying cosmetic genital surgery until the individual can participate in the decision
- When surgery is performed (e.g., clitoral reduction/clitoroplasty in severe virilization), nerve-sparing techniques preserving the neurovascular bundle are used to protect sexual sensation
- There is international variation in practice and ongoing ethical debate; some centers and advocacy groups argue for delaying all non-urgent genital surgery, while others support earlier intervention in select severe cases with full family involvement
Psychosocial support
- Counseling and psychological support for patients and families are an integral part of DSD care, not an afterthought
- Peer support groups and long-term follow-up into adulthood are recommended
Complications and prognosis
- Untreated salt-wasting CAH in neonates can cause life-threatening adrenal crisis with hypotension, hyperkalemia, and shock
- Psychosocial distress, body image concerns, and gender identity considerations are important long-term issues, particularly when surgery is performed in infancy without the patient's input
- Surgical complications of clitoral reduction can include altered sensation, scarring, and need for revision surgery
- With appropriate hormonal management, CAH-related clitoromegaly in children does not worsen and fertility can often be preserved
- Prognosis for androgen-secreting tumors depends on whether the lesion is benign or malignant and whether complete resection is achieved
- Long-term outcomes are best with multidisciplinary, individualized care rather than a one-size-fits-all surgical approach
CLIT: Congenital adrenal hyperplasia, Luteoma/tumor (androgen-secreting), Iatrogenic/exogenous androgens, Testosterone excess from PCOS
Practice questions
1. A female newborn is noted to have an enlarged clitoris and partially fused labia at birth. On day 10 of life, she develops vomiting, poor feeding, and lethargy. Serum sodium is 128 mEq/L and potassium is 6.2 mEq/L. Which of the following is the most likely diagnosis?
2. A 32-year-old woman presents with new hirsutism, clitoromegaly, and deepening of her voice that developed over the past 4 months. She has regular menses until 6 months ago. Testosterone is markedly elevated at 250 ng/dL (normal less than 70 ng/dL). Which of the following is the most appropriate next step?
3. A 46,XX infant with CAH and clitoromegaly is being evaluated by a multidisciplinary DSD team. The parents ask about genital surgery. Which statement best reflects current major guideline consensus?
Frequently asked questions
What causes clitoromegaly?
Clitoromegaly is caused by excess androgen exposure, either congenital (most often 21-hydroxylase deficiency CAH, or maternal androgen exposure in pregnancy) or acquired (androgen-secreting ovarian or adrenal tumors, PCOS, exogenous anabolic steroids, or Cushing syndrome). Rarely, non-hormonal causes like lymphedema or neurofibroma mimic true clitoral enlargement.
What are the first symptoms of clitoromegaly in a newborn?
In a newborn, the first sign is often an enlarged clitoris noted at birth alongside ambiguous-appearing genitalia or labial fusion. If the underlying cause is salt-wasting CAH, poor feeding, vomiting, and dehydration typically appear within the first one to two weeks of life and require urgent evaluation.
How is clitoromegaly diagnosed?
Diagnosis starts with measuring clitoral size and examining for labial fusion or palpable gonads, followed by hormone testing. In neonates, 17-hydroxyprogesterone is checked first to screen for CAH; in adults, testosterone and DHEA-S are measured, with pelvic or adrenal imaging if a tumor is suspected.
Is clitoromegaly curable?
Whether it resolves depends entirely on the cause. Clitoromegaly from an androgen-secreting tumor often improves significantly after the tumor is removed, and CAH-related enlargement can be controlled with hormone therapy, though structural changes already present may need separate management, including possible surgery.
Clitoromegaly vs labial fusion — what is the difference?
Clitoromegaly is enlargement of the clitoris itself, while labial fusion is the joining of the labia minora and/or majora in the midline. Both can occur together in congenital adrenal hyperplasia from prenatal androgen exposure, but a child can have one without the other, so each should be assessed and documented separately on exam.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: Q52.6
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.